Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer

SIMPLE SUMMARY: Patients diagnosed with endometrial cancer (EC), the most common gynaecological malignancy in women worldwide, cope with a disease associated with poor prognosis and limited treatment options after first-line therapy when it reaches an advanced or metastatic stage. Lately, small-mole...

Descripción completa

Detalles Bibliográficos
Autores principales: Megino-Luque, Cristina, Moiola, Cristian Pablo, Molins-Escuder, Clara, López-Gil, Carlos, Gil-Moreno, Antonio, Matias-Guiu, Xavier, Colas, Eva, Eritja, Núria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598629/
https://www.ncbi.nlm.nih.gov/pubmed/32987790
http://dx.doi.org/10.3390/cancers12102751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598629/
https://www.ncbi.nlm.nih.gov/pubmed/32987790
http://dx.doi.org/10.3390/cancers12102751

Ejemplares similares